Iron Chelators in Treatment of Iron Overload

Patients suffering from iron overload can experience serious complications. In such patients, various organs, such as endocrine glands and liver, can be damaged. Although iron is a crucial element for life, iron overload can be potentially toxic for human cells due to its role in generating free rad...

Full description

Saved in:
Bibliographic Details
Main Authors: Sarina Entezari, Seyedeh Mona Haghi, Narges Norouzkhani, Barsa Sahebnazar, Fatemeh Vosoughian, Diba Akbarzadeh, Muhammad Islampanah, Navid Naghsh, Mohammad Abbasalizadeh, Niloofar Deravi
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Toxicology
Online Access:http://dx.doi.org/10.1155/2022/4911205
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562541665976320
author Sarina Entezari
Seyedeh Mona Haghi
Narges Norouzkhani
Barsa Sahebnazar
Fatemeh Vosoughian
Diba Akbarzadeh
Muhammad Islampanah
Navid Naghsh
Mohammad Abbasalizadeh
Niloofar Deravi
author_facet Sarina Entezari
Seyedeh Mona Haghi
Narges Norouzkhani
Barsa Sahebnazar
Fatemeh Vosoughian
Diba Akbarzadeh
Muhammad Islampanah
Navid Naghsh
Mohammad Abbasalizadeh
Niloofar Deravi
author_sort Sarina Entezari
collection DOAJ
description Patients suffering from iron overload can experience serious complications. In such patients, various organs, such as endocrine glands and liver, can be damaged. Although iron is a crucial element for life, iron overload can be potentially toxic for human cells due to its role in generating free radicals. In the past few decades, there has been a major improvement in the survival of patients who suffer from iron overload due to the application of iron chelation therapy in clinical practice. In clinical use, deferoxamine, deferiprone, and deferasirox are the three United States Food and Drug Administration-approved iron chelators. Each of these iron chelators is well known for the treatment of iron overload in various clinical conditions. Based on several up-to-date studies, this study explained iron overload and its clinical symptoms, introduced each of the above-mentioned iron chelators, and evaluated their advantages and disadvantages with an emphasis on combination therapy, which in recent studies seems a promising approach. In numerous clinical conditions, due to the lack of accurate indicators, choosing a standard approach for iron chelation therapy can be difficult; therefore, further studies on the issue are still required. This study aimed to introduce each of these iron chelators, combination therapy, usage doses, specific clinical applications, and their advantages, toxicity, and side effects.
format Article
id doaj-art-886f87c1a0524308a3c2dd3ecf253e71
institution Kabale University
issn 1687-8205
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Journal of Toxicology
spelling doaj-art-886f87c1a0524308a3c2dd3ecf253e712025-02-03T01:22:27ZengWileyJournal of Toxicology1687-82052022-01-01202210.1155/2022/4911205Iron Chelators in Treatment of Iron OverloadSarina Entezari0Seyedeh Mona Haghi1Narges Norouzkhani2Barsa Sahebnazar3Fatemeh Vosoughian4Diba Akbarzadeh5Muhammad Islampanah6Navid Naghsh7Mohammad Abbasalizadeh8Niloofar Deravi9Student Research CommitteeStudent Research CommitteeDepartment of Medical InformaticsStudent Research CommitteeStudent Research CommitteeStudent Research CommitteeFaculty of MedicineDepartment of PharmacyFaculty of MedicineStudent Research CommitteePatients suffering from iron overload can experience serious complications. In such patients, various organs, such as endocrine glands and liver, can be damaged. Although iron is a crucial element for life, iron overload can be potentially toxic for human cells due to its role in generating free radicals. In the past few decades, there has been a major improvement in the survival of patients who suffer from iron overload due to the application of iron chelation therapy in clinical practice. In clinical use, deferoxamine, deferiprone, and deferasirox are the three United States Food and Drug Administration-approved iron chelators. Each of these iron chelators is well known for the treatment of iron overload in various clinical conditions. Based on several up-to-date studies, this study explained iron overload and its clinical symptoms, introduced each of the above-mentioned iron chelators, and evaluated their advantages and disadvantages with an emphasis on combination therapy, which in recent studies seems a promising approach. In numerous clinical conditions, due to the lack of accurate indicators, choosing a standard approach for iron chelation therapy can be difficult; therefore, further studies on the issue are still required. This study aimed to introduce each of these iron chelators, combination therapy, usage doses, specific clinical applications, and their advantages, toxicity, and side effects.http://dx.doi.org/10.1155/2022/4911205
spellingShingle Sarina Entezari
Seyedeh Mona Haghi
Narges Norouzkhani
Barsa Sahebnazar
Fatemeh Vosoughian
Diba Akbarzadeh
Muhammad Islampanah
Navid Naghsh
Mohammad Abbasalizadeh
Niloofar Deravi
Iron Chelators in Treatment of Iron Overload
Journal of Toxicology
title Iron Chelators in Treatment of Iron Overload
title_full Iron Chelators in Treatment of Iron Overload
title_fullStr Iron Chelators in Treatment of Iron Overload
title_full_unstemmed Iron Chelators in Treatment of Iron Overload
title_short Iron Chelators in Treatment of Iron Overload
title_sort iron chelators in treatment of iron overload
url http://dx.doi.org/10.1155/2022/4911205
work_keys_str_mv AT sarinaentezari ironchelatorsintreatmentofironoverload
AT seyedehmonahaghi ironchelatorsintreatmentofironoverload
AT nargesnorouzkhani ironchelatorsintreatmentofironoverload
AT barsasahebnazar ironchelatorsintreatmentofironoverload
AT fatemehvosoughian ironchelatorsintreatmentofironoverload
AT dibaakbarzadeh ironchelatorsintreatmentofironoverload
AT muhammadislampanah ironchelatorsintreatmentofironoverload
AT navidnaghsh ironchelatorsintreatmentofironoverload
AT mohammadabbasalizadeh ironchelatorsintreatmentofironoverload
AT niloofarderavi ironchelatorsintreatmentofironoverload